Abnormal sensorimotor plasticity in CADASIL correlates with neuropsychological impairment

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 3, 2013, Pages 329-336

  Palomar, Francisco J ^a,b   Suárez, Aida ^a   Franco, Emilio ^a   Carrillo, Fátima ^a   Gil Néciga, Eulogio ^a   Mir, Pablo ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ACETYLSALICYLIC ACID; GLUTAMIC ACID;

ADULT; AGED; ARTICLE; CADASIL; CHOLINERGIC TRANSMISSION; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; FACILITATION; FEMALE; GABAERGIC TRANSMISSION; HUMAN; LONG TERM POTENTIATION; MALE; MEMORY DISORDER; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORIMOTOR PLASTICITY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84874105920     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303960     Document Type: Article

References (40)

1. Viswanathan A, Gray F, Bousser M.G., et al Cortical neuronal apoptosis in CADASIL. Stroke 2006; 37: 2690-5.
2. Chabriat H, Vahedi K, Iba-Zizen MT, et al Clinical spectrum of CADASIL: a study of 7 families. Lancet 1995; 346: 934-9.
3. Desmond DW, Moroney JT, Lynch T, et al The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 1999; 30: 1230-3.
4. Selden NR, Gitelman DR, Salamon-Murayama N, et al Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998; 121: 2249-57.
5. Swartz RH, Sahlas DJ, Black SE Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter? J Stroke Cerebrovasc Dis 2003; 12: 29-36.
6. Morari M, Marti M, Sbrenna S., et al Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int 1998; 33: 383-97.
7. Tepper JM, Lee CR GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 2007; 160: 189-208.
8. Pennisi G, Ferri R, Alagona G., et al Motor cortex hyperexcitability in subcortical ischemic vascular dementia. Arch Gerontol Geriatr 2011; 53:e111-13.
9. Alagona G, Bella R, Ferri R., et al Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett 2001; 314: 57-60.
10. Di Lazzaro V., Oliviero A, Tonali P.A., et al Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002; 59: 392-7.
11. Di Lazzaro V., Oliviero A, Pilato F., et al Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004; 75: 555-9.
12. Inghilleri M, Conte A, Frasca V., et al Altered response to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 2006; 17: 103-9.
13. Di Lazzaro V., Pilato F, Dileone M., et al In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin Neurophysiol 2008; 119: 2494-500.
14. Manganelli F, Ragno M, Cacchiò G, et al. Motor cortex cholinergic dysfunction in CADASIL: a transcranial magnetic demonstration. Clin Neurophysiol 2008; 119: 351-5.
15. Folstein MF, Folstein SE, McHugh PR "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
16. Bella R, Ferri R, Cantone M., et al Motor cortex excitability in vascular depression. Int J Psychophysiol 2011; 82: 248-53.
17. Pescini F, Nannucci S, Bertaccini B., et al The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke 2012; 43: 2871-6.
18. Charlton RA, Morris RG, Nitkunan A, et al The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology 2006; 66: 1523-1526.
19. Nardone R, Lochner P, Marth R., et al Abnormal intracortical facilitation in early-stage Huntington's disease. Clin Neurophysiol 2007; 118: 1149-54.
20. Hwa GG, Avoli M. Excitatory synaptic transmission mediated by NMDA and non-NMDA receptors in the superficial/middle layers of the epileptogenic human neocortex maintained in vitro. Neurosci Lett 1992; 143: 83-6.
21. Ziemann U, Lönnecker S, Steinhoff B.J., et al Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996; 40: 367-78.
22. Ziemann U, Chen R, Cohen L.G., et al Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998; 51: 1320-4.
23. Schwenkreis P, Witscher K, Janssen F., et al Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability. Neurosci Lett 1999; 270: 137-40.
24. Schwenkreis P, Liepert J, Witscher K., et al Riluzole suppresses motor cortex facilitation in correlation to its plasma level: a study using transcranial magnetic stimulation. Exp Brain Res 2000; 135: 293-9.
25. Di Lazzaro V., Oliviero A, Meglio M., et al Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 2000; 111: 794-99.
26. Di Lazzaro V., Oliviero A, Saturno E., et al Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 2005; 564: 661-8.
27. Dichgans M, Markus HS, Salloway S, et al Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008; 7: 310-18.
28. List J, Duning T, Meinzer M., et al Enhanced rapid-onset cortical plasticity in CADASIL as a possible mechanism of preserved cognition. Cereb Cortex 2011; 21: 2774-87.
29. List J, Duning T, Kürten J, et al Cortical plasticity is preserved in nondemented older individuals with severe ischemic small vessel disease. Hum Brain Mapp Published Online First: 14 Feb 2012. doi:10.1002/hbm.22003.
30. Kujirai K, Kujirai T, Sinkjaer T., et al Associative plasticity in human motor cortex during voluntary muscle contraction. J Neurophysiol 2006; 96: 1337-46.
31. McDonnell MN, Orekhov Y, Ziemann U. Suppression of LTP-like plasticity in human motor cortex by the GABAB receptor agonist baclofen. Exp Brain Res 2007; 180: 181-6.
32. Stefan K, Kunesch E, Benecke R., et al Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol 2002; 543: 699-708.
33. O'Sullivan M., Jarosz JM, Martin R.J., et al MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001; 56: 628-34.
34. Metherate R, Ashe JH Synaptic interactions involving acetylcholine, glutamate, and GABA in rat auditory cortex. Exp Brain Res 1995; 107: 59-72.
35. Buffon F, Porcher R, Hernandez K., et al Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006; 77: 175-80.
36. Peters N, Opherk C, Danek A., et al The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry 2005; 162: 2078-85.
37. Marra C, Quaranta D, Profice P., et al Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body. Brain Stimul 2012; 5: 533-8.
38. Blanco Menéndez R, Aguado Balsas AM, Blanco E, et al. The CADASIL syndrome: a model of subcortical-cortical disconnection. Rev Neurol 2001; 32: 750-4.
39. Morgante F, Espay AJ, Gunraj C, et al Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006; 129: 1059-69.
40. Battaglia F, Wang HY, Ghilardi M.F., et al Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 2007; 62: 1405-12.